Switzerland reviews third anti-viral Covid vaccine
The race is on worldwide to provide the first Covid-19 vaccine
Copyright 2020 The Associated Press. All Rights Reserved.
The Swiss therapeutics products agency Swissmedic has started a review of another anti-Covid 19 vaccine – this time from United States biotech firm Moderna - in the rolling submission procedure.
This content was published on
2 minutes
Keystone-SDA/Swissmedic/SWI swissinfo.ch/ilj
This is the third authorisation procedure submitted in Switzerland for a vaccine against the novel coronavirus.
“The rolling submission procedure for mRNA-1273 is based on the initially submitted data packages on the preclinical situation and quality, as well as on preliminary clinical data. In a rolling review, the data can be evaluated as soon as they become available. The companies can then submit the latest data continuously without having to wait for the conclusive results from all studies,” Swissmedic said on FridayExternal link.
Swissmedic can thus obtain an initial picture of the benefit-risk profile of the vaccine candidates before the authorisation studies are completed (Phase III studies). This accelerates the review process while at the same time “preserving the same level of careful checking of all requirements relating to safety, efficacy and quality”, it explained.
The agency is already reviewing authorisation applications for Covid-19 vaccines from the companies AstraZeneca and Pfizer/BioNTech.
Vaccine strategy
On Wednesday Swiss government announced that it had earmarked an additional CHF100 million ($111 million) to buy an anti-Covid vaccine.
Interior Minister Alain Berset said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year.
So far, Switzerland has assured reservations for about 13 million doses of prospective vaccines from AstraZeneca and Moderna and an international programme by the World Health OrganizationExternal link (WHO). It is also in negotiations with Pfizer/BioNTech about assuring delivery. Swissmedic has to examine and approve any product before it is distributed.
Health officials estimate about 60-70% of the population must be inoculated against the new coronavirus to get the pandemic under control.
Coronavirus infections in Switzerland rose by 6,739, the federal health authorities said on Friday. The death toll increased by 97.
More
More
Swiss stump up more cash to buy a Covid-19 vaccine
This content was published on
Interior Minister Alain Berset, who announced the news on Wednesday, said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year. So far, Switzerland has assured reservations for about 13 million doses of prospective…
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Prevention and tech could help save billions on Swiss healthcare costs, says Deloitte
This content was published on
By focusing on prevention and technology, it would be possible to reduce Switzerland's healthcare bill by CHF30 billion a year by 2040, according to Deloitte Switzerland.
Environment director warns of increasing climate-related risks in Switzerland
This content was published on
The director of the Swiss Federal Office for the Environment (FOEN) has warned of increasing climate-related risks in Switzerland in an interview with SonntagsBlick on Sunday.
Gotthard traffic queue hits 11km at start of holiday season
This content was published on
The start of the summer holidays saw a long traffic jam in front of the Gotthard tunnel on Saturday. Traffic jams between Erstfeld and Göschenen in canton Uri were up to 11 kilometres long early in the morning.
This content was published on
The water temperature of the Rhine River could rise by up to 4.2° degrees Celsius by the end of the century due to the warming planet, scientists warn.
This content was published on
The Federal Council wants to explore the possibilities of joining the European Union’s €800-billion rearmament programme without compromising Swiss neutrality.
Defence Minister Pfister stresses importance of Swiss mission in Balkans
This content was published on
During a visit to the Balkans region last week, Swiss Defence Minister Martin Pfister met Swisscoy peacekeeping troops in Kosovo.
Premiere for Swiss Air Force on French National Day
This content was published on
On July 14, the Swiss Air Force will take part in the traditional air parade in Paris to mark the French bank holidays with an F/A-18 fighter jet. This is a first for Switzerland.
Swiss launch competition for memorial to Nazi victims
This content was published on
The victims of Nazi Germany are to be commemorated on the Casinoterrasse in Bern. A competition will be held to determine what the site will look like.
This content was published on
The Swiss therapeutic products agency has begun reviewing another anti-Covid 19 vaccine in the rolling submission procedure.
This content was published on
Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.